230 related articles for article (PubMed ID: 12762830)
1. Thalidomide in cutaneous lupus erythematosus.
Pelle MT; Werth VP
Am J Clin Dermatol; 2003; 4(6):379-87. PubMed ID: 12762830
[TBL] [Abstract][Full Text] [Related]
2. Low-dose thalidomide is an effective second-line treatment in cutaneous lupus erythematosus.
Thomson KF; Goodfield MJ
J Dermatolog Treat; 2001 Sep; 12(3):145-7. PubMed ID: 12243705
[TBL] [Abstract][Full Text] [Related]
3. Low-dose thalidomide therapy for refractory cutaneous lesions of lupus erythematosus.
Housman TS; Jorizzo JL; McCarty MA; Grummer SE; Fleischer AB; Sutej PG
Arch Dermatol; 2003 Jan; 139(1):50-4. PubMed ID: 12533164
[TBL] [Abstract][Full Text] [Related]
4. American experience with low-dose thalidomide therapy for severe cutaneous lupus erythematosus.
Duong DJ; Spigel GT; Moxley RT; Gaspari AA
Arch Dermatol; 1999 Sep; 135(9):1079-87. PubMed ID: 10490113
[TBL] [Abstract][Full Text] [Related]
5. Thalidomide for the treatment of resistant cutaneous lupus: efficacy and safety of different therapeutic regimens.
Cuadrado MJ; Karim Y; Sanna G; Smith E; Khamashta MA; Hughes GR
Am J Med; 2005 Mar; 118(3):246-50. PubMed ID: 15745722
[TBL] [Abstract][Full Text] [Related]
6. Thalidomide treatment in cutaneous lesions of systemic lupus erythematosus: a multicenter study in China.
Wang D; Chen H; Wang S; Zou Y; Li J; Pan J; Wang X; Ren T; Zhang Y; Chen Z; Feng X; Sun L
Clin Rheumatol; 2016 Jun; 35(6):1521-7. PubMed ID: 27097914
[TBL] [Abstract][Full Text] [Related]
7. [Rediscovery of thalidomide. Successful treatment of discoid lupus erythematosus].
Kuhn A; Hefter H; Ruzicka T; Lehmann P
Hautarzt; 2001 Aug; 52(8):726-33. PubMed ID: 11544946
[TBL] [Abstract][Full Text] [Related]
8. Thalidomide in the treatment of refractory cutaneous lupus erythematosus: prognostic factors of clinical outcome.
Cortés-Hernández J; Torres-Salido M; Castro-Marrero J; Vilardell-Tarres M; Ordi-Ros J
Br J Dermatol; 2012 Mar; 166(3):616-23. PubMed ID: 21999437
[TBL] [Abstract][Full Text] [Related]
9. [Thalidomide therapy of cutaneous lupus erythematosus].
Bohmeyer J; Achenbach A; Westenberger M; Stadler R
Hautarzt; 2002 Nov; 53(11):744-8. PubMed ID: 12402138
[TBL] [Abstract][Full Text] [Related]
10. Thalidomide: an experience in therapeutic outcome and adverse reactions.
Sharma NL; Sharma VC; Mahajan VK; Shanker V; Ranjan N; Gupta M
J Dermatolog Treat; 2007; 18(6):335-40. PubMed ID: 17852637
[TBL] [Abstract][Full Text] [Related]
11. Thalidomide neurotoxicity: prospective study in patients with lupus erythematosus.
Briani C; Zara G; Rondinone R; Della Libera S; Ermani M; Ruggero S; Ghirardello A; Zampieri S; Doria A
Neurology; 2004 Jun; 62(12):2288-90. PubMed ID: 15210897
[TBL] [Abstract][Full Text] [Related]
12. Pustuloderma during cutaneous lupus treatment with thalidomide.
Rúa-Figueroa I; Erausquin C; Naranjo A; Carretero-Hernández G; Rodriguez-Lozano C; De la Rosa P
Lupus; 1999; 8(3):248-9. PubMed ID: 10342720
[No Abstract] [Full Text] [Related]
13. Thalidomide: current and potential clinical applications.
Calabrese L; Fleischer AB
Am J Med; 2000 Apr; 108(6):487-95. PubMed ID: 10781782
[TBL] [Abstract][Full Text] [Related]
14. Thalidomide in the treatment of cutaneous lupus refractory to conventional therapy.
Ordi-Ros J; Cortés F; Cucurull E; Mauri M; Buján S; Vilardell M
J Rheumatol; 2000 Jun; 27(6):1429-33. PubMed ID: 10852265
[TBL] [Abstract][Full Text] [Related]
15. Thalidomide: dermatological indications, mechanisms of action and side-effects.
Wu JJ; Huang DB; Pang KR; Hsu S; Tyring SK
Br J Dermatol; 2005 Aug; 153(2):254-73. PubMed ID: 16086735
[TBL] [Abstract][Full Text] [Related]
16. Successful long-term thalidomide therapy for discoid lupus erythematosus-lichen planus overlap syndrome.
Zhang L; Au S; Aronson IK
Dermatol Online J; 2014 Oct; 20(10):. PubMed ID: 25526013
[TBL] [Abstract][Full Text] [Related]
17. Thalidomide for treatment of severe generalized discoid lupus lesions in two patients with systemic lupus erythematosus.
Alfadley A; Al-Rayes H; Hussein W; Al-Dalaan A; Al-Aboud K
J Am Acad Dermatol; 2003 May; 48(5 Suppl):S89-91. PubMed ID: 12734488
[TBL] [Abstract][Full Text] [Related]
18. A case of herpes zoster during pimecrolimus use for the treatment of subacute cutaneous lupus erythematosus.
Tatlican S; Eren C; Atacan D; Dalgic U; Canpolat F; Eskioglu F
J Dermatolog Treat; 2010 Sep; 21(5):322-3. PubMed ID: 19832287
[No Abstract] [Full Text] [Related]
19. Treatment of the cutaneous lesions of systemic lupus erythematosus with thalidomide.
Atra E; Sato EI
Clin Exp Rheumatol; 1993; 11(5):487-93. PubMed ID: 8275583
[TBL] [Abstract][Full Text] [Related]
20. Long-term thalidomide use in refractory cutaneous lesions of lupus erythematosus: a 65 series of Brazilian patients.
Coelho A; Souto MI; Cardoso CR; Salgado DR; Schmal TR; Waddington Cruz M; de Souza Papi JA
Lupus; 2005; 14(6):434-9. PubMed ID: 16038106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
